Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $338.19 | $19.33 | 1,649.90% | 6,763.80x | 99.83x | 7.49x | 9.07x | 6.53x | $529.27M | 1.42% | $4.13B | 37.48 | $35.33B | 111.09 | ||
| NVO | NOVO NORDISK A S | $62.33 | $148.64 | -58.07% | 17.33x | 2.74x | 5.70x | 10.58x | 0.18x | $9.34B | 3.37% | $26.18B | 5.89 | $287.62B | 11.59 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $359.27 | $37.01 | 870.63% | 1,158.94x | 50.16x | 14.71x | 202.93x | 3.75x | $221.36M | 0.47% | $233.89M | 1.78 | $49.19B | 323.76 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $39.41 | $17.39 | 126.66% | 80.43x | 22.90x | 4.92x | 5.58x | 0.99x | $101.73M | 3.46% | $535.38M | 7.17 | $2.82B | 52.67 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.93 | $16.47 | -45.79% | 18.60x | 15.70x | 5.92x | 3.78x | 0.24x | -$23.64M | -4.74% | $133.17M | 2.38 | $511.01M | 7.60 | ||
| CORT | CORCEPT THERAPEUTICS INC | $34.73 | $41.59 | -16.48% | 34.73x | 69.21x | 4.85x | 5.78x | 0.36x | $162.57M | 4.52% | $631.90M | 6.10 | $3.53B | 53.57 | ||
| ARGX | ARGENX SE | $800.01 | $371.09 | 115.58% | 31.97x | 26.68x | 25,806.77x | 6.81x | 1.30x | $467.72M | 0.96% | $7.17B | 117.50 | $46.42B | 57.22 | ||
| VCEL | VERICEL CORP | $37.40 | $9.57 | 290.87% | 143.85x | 64.33x | 7.30x | 5.88x | 1.70x | $20.38M | 1.08% | $321.86M | 6.38 | $1.89B | 64.45 | ||
| GMAB | GENMAB A | $32.25 | $128.20 | -74.84% | 13.76x | 1.91x | 5.81x | 3.60x | 0.10x | $1.19B | 5.77% | $5.75B | 8.96 | $19.09B | 9.54 | ||
| KRYS | KRYSTAL BIOTECH INC | $285.04 | $116.08 | 145.55% | 41.31x | 35.17x | 22.11x | 7.26x | 1.37x | $166.02M | 2.01% | $1.14B | 39.30 | $7.88B | 40.78 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.25 | $19.16 | -72.60% | 3.30x | -97.40x | 750.00x | 1.66x | 0.19x | -$82.36M | -28.91% | $171.23M | 3.16 | $225.39M | 2.51 | ||
| TECH | BIO-TECHNE CORP | $68.67 | $16.27 | 322.11% | 137.34x | 34.00x | 8.77x | 5.44x | 1.89x | $224.06M | 2.10% | $1.97B | 12.65 | $10.95B | 49.57 | ||
| ADMA | ADMA BIOLOGICS INC | $17.31 | $12.77 | 35.53% | 19.67x | 18.96x | 8.45x | 9.55x | 0.83x | $40.73M | 0.99% | $431.19M | 1.81 | $4.13B | 24.01 | ||
| RPRX | ROYALTY PHARMA PLC | $39.55 | $47.36 | -16.49% | 22.47x | 7.62x | 7.27x | 2.37x | 0.39x | $2.11B | 12.36% | $9.62B | 22.28 | $30.84B | 29.53 | ||
| XOMA | XOMA ROYALTY CORP | $26.37 | $15.89 | 65.95% | 32.56x | 83.87x | 6.79x | 3.71x | 0.86x | -$12.41M | -3.88% | $87.94M | 7.25 | $367.98M | 13.76 | ||
| VCYT | VERACYTE INC | $41.57 | $12.67 | 228.14% | 106.59x | 38.85x | 6.61x | 2.61x | 1.47x | $98.21M | 3.00% | $1.26B | 15.98 | $3.01B | 52.80 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $192.97 | $72.48 | 166.24% | 83.54x | 22.81x | 15.04x | 4.00x | 1.20x | $30.76M | 0.81% | $950.17M | 48.53 | $4.11B | 39.89 | ||
| MNKD | MANNKIND CORP | $5.21 | $2.93 | 77.94% | 52.10x | 42.57x | 5.09x | -35.91x | 0.81x | $43.39M | 2.71% | -$44.55M | -0.15 | $1.83B | 25.04 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.19 | $4.33 | 42.79% | 22.93x | 20.57x | 3.96x | 6.99x | 0.82x | $21.15M | 4.28% | $70.68M | 0.89 | $432.77M | 19.07 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.85 | $9.87 | 50.40% | 25.60x | 15.57x | 7.36x | 5.35x | 0.84x | $119.87M | 6.12% | $365.77M | 2.78 | $1.96B | 18.96 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.22 | $61.43 | -41.04% | 11.21x | 8.57x | 2.52x | 2.50x | 0.31x | $296.89M | 14.24% | $835.12M | 14.51 | $1.61B | 5.96 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $441.36 | $190.78 | 131.34% | 30.84x | 21.68x | 9.62x | 6.47x | 1.50x | $3.34B | 2.96% | $17.32B | 67.76 | $108.88B | 23.35 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.04 | $3.58 | -43.07% | 29.14x | 11.54x | 2.62x | 3.10x | 0.24x | -$11.69M | -7.21% | $52.91M | 0.67 | $158.59M | 17.88 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.70 | $23.49 | -3.37% | 12.68x | 12.33x | 4.81x | 3.03x | 0.63x | $234.54M | 8.43% | $920.25M | 7.51 | $2.10B | 6.49 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.59 | $51.31 | 6.40% | 20.07x | 11.76x | 3.39x | 1.73x | 0.56x | $832.13M | 7.94% | $6.06B | 31.54 | $9.83B | 12.73 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $19.94 | $6.51 | 206.07% | 56.97x | -17.59x | 2.48x | 6.29x | 1.63x | $78.64M | 3.12% | $401.17M | 3.17 | $2.52B | 26.96 | ||
| CRMD | CORMEDIX INC | $6.78 | $15.12 | -55.15% | 2.99x | 3.58x | 2.40x | 1.43x | 1.23x | $74.42M | 14.45% | $374.13M | 4.93 | $634.62M | 5.65 | ||
| EXEL | EXELIXIS INC | $43.96 | $36.62 | 20.06% | 17.87x | 13.56x | 5.16x | 5.45x | 0.72x | $779.77M | 6.61% | $2.16B | 8.05 | $11.59B | 12.49 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.21 | $81.20 | -12.31% | 14.56x | 8.52x | 6.72x | 16.62x | 0.49x | $602.40M | 7.22% | $503.92M | 4.30 | $9.47B | 11.20 | ||
| MDXG | MIMEDX GROUP INC | $5.42 | $5.08 | 6.80% | 19.36x | 21.69x | 2.04x | 3.36x | 0.58x | $66.82M | 8.32% | $238.95M | 1.61 | $678.84M | 9.81 | ||
| INVA | INNOVIVA INC | $19.44 | $19.45 | -0.06% | 10.29x | 8.90x | 3.46x | 1.44x | 0.84x | $196.54M | 14.64% | $1.01B | 14.63 | $1.23B | 5.75 | ||
| UTHR | UNITED THERAPEUTICS CORP | $464.93 | $255.82 | 81.74% | 16.32x | 15.78x | 6.51x | 3.04x | 1.86x | $1.12B | 5.51% | $6.59B | 150.46 | $18.68B | 10.53 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $25.99 | $12.31 | 111.09% | 16.55x | 32.21x | 4.19x | 4.79x | 2.93x | $197.81M | 4.51% | $917.27M | 5.43 | $4.17B | 14.50 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $733.04 | $415.75 | 76.32% | 16.87x | 15.86x | 5.33x | 2.49x | 1.63x | $4.22B | 5.56% | $30.96B | 298.82 | $77.24B | 13.52 | ||
| INCY | INCYTE CORP | $106.21 | $76.79 | 38.31% | 17.58x | 13.22x | 4.32x | 4.48x | 0.93x | $1.20B | 5.76% | $4.65B | 23.77 | $18.43B | 10.95 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.